Comparative bioavailability of a drug in a peg based solution using an iprecio® pump infusion and subcutaneous bolus
- In: Poster presentation
- At: Seoul (South Korea) (2017)
- Type: Poster
- Poster code: POS-PAA-020
- By: TEIXEIRA, João (Bial - Portela & Cª, S.A., R&D Department, Trofa, Portugal)
- Co-author(s): João Teixeira: R&D Department, Bial - Portela & Cª, S.A., Trofa, Portugal
Nuno Pires: R&D Department, Bial - Portela & Cª, S.A., Trofa, Portugal
Bruno Igreja: R&D Department, Bial - Portela & Cª, S.A., Trofa, Portugal
Ana Loureiro: R&D Department, Bial - Portela & Cª, S.A., Trofa, Portugal
Teófilo Vasconcelos: R&D Department, Bial - Portela & Cª, S.A., Trofa, Portugal
Ricardo Lima: R&D Department, Bial - Portela & Cª, S.A., Trofa, Portugal
Patrício Soares-da-Silva: R&D Department, Bial - Portela & Cª, S.A., Trofa, Portugal;MedInUP, Center for Drug Discovery and Innovative Medicines, University of Porto, Porto, Portugal - Abstract:
Background
iPrecio® microinfusion pumps are programmable, implantable and refillable devices for small animal experimentation, showing advantages over the subcutaneous (SC) bolus administration.
Purpose
The aim of this study was to compare the plasma and brain time course pharmacokinetic (PK) profile of a drug delivered from iPrecio pumps versus a SC
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023